Deutsche Bank
CXM

Deutsche Bank’s CARDIUM THERAPEUTICS INC NEW CXM Stock Holding History

Deutsche Bank’s Portfolio CXM Stock Details CXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,262
Closed -$2K – 6034
2013
Q3 		$2K Buy
+2,262
New +$2.3K ﹤0.01% 5364

Other funds holding CXM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Deutsche Bank's CXM Position: Q4 2013 in Review

Deutsche Bank sold out of CARDIUM THERAPEUTICS INC NEW (CXM) in Q4 2013, closing a stake of 2,262 shares — an estimated $2K sold.

Deutsche Bank first reported a position in CXM in Q3 2013 and held it in 1 quarter. The position peaked at $2K in Q3 2013. 8 funds tracked by Wall St. Rank hold CXM as of Q4 2013.

  • Deutsche Bank reported no remaining CARDIUM THERAPEUTICS INC NEW position as of Q4 2013 after selling out during the quarter.
  • Deutsche Bank sold 2,262 CARDIUM THERAPEUTICS INC NEW shares in Q4 2013, an estimated $2K.
  • Deutsche Bank first reported a position in CARDIUM THERAPEUTICS INC NEW in Q3 2013 and held it in 1 quarter.
  • Deutsche Bank's CARDIUM THERAPEUTICS INC NEW position peaked at $2K in Q3 2013.
  • 8 funds tracked by Wall St. Rank held CARDIUM THERAPEUTICS INC NEW as of Q4 2013.

Based on Deutsche Bank's 13F filing for Q4 2013, filed 18 Feb 2014.